MedCity News October 18, 2024
Jan Schulte

Organizations are delivering digital experiences and content to HCPs on a much larger scale than was previously possible. Integrating digital tools will advance things even further and help marketers and MLR teams maintain brand consistency and ensure compliance across digital and content operations.

What a difference a few years make. Previously, digital strategy in the biopharma industry consisted of a series of isolated projects and fragmented channels, websites, and portals. Today, omnichannel digital engagement is the way of doing business, driven by declining in-person access to healthcare professionals (HCPs).

Over this time, the number of digital-savvy HCPs has increased, as physicians prefer to engage biopharma brands in a variety of digital channels. At the center of the industry’s transformation is...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Provider
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
GLP-1 drug coverage for obesity making inroads with large employers: Mercer

Share This Article